Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Kezar Life Sciences (KZR) Interest Expenses (2021 - 2025)

Historic Interest Expenses for Kezar Life Sciences (KZR) over the last 5 years, with Q2 2025 value amounting to $302000.0.

  • Kezar Life Sciences' Interest Expenses fell 2468.83% to $302000.0 in Q2 2025 from the same period last year, while for Sep 2025 it was $1.0 million, marking a year-over-year decrease of 3524.64%. This contributed to the annual value of $1.6 million for FY2024, which is 277.42% up from last year.
  • Per Kezar Life Sciences' latest filing, its Interest Expenses stood at $302000.0 for Q2 2025, which was down 2468.83% from $347000.0 recorded in Q1 2025.
  • Over the past 5 years, Kezar Life Sciences' Interest Expenses peaked at $403000.0 during Q3 2024, and registered a low of $159000.0 during Q4 2021.
  • For the 5-year period, Kezar Life Sciences' Interest Expenses averaged around $342400.0, with its median value being $370000.0 (2023).
  • As far as peak fluctuations go, Kezar Life Sciences' Interest Expenses skyrocketed by 11949.69% in 2022, and later plummeted by 2468.83% in 2025.
  • Over the past 5 years, Kezar Life Sciences' Interest Expenses (Quarter) stood at $159000.0 in 2021, then soared by 119.5% to $349000.0 in 2022, then rose by 14.33% to $399000.0 in 2023, then dropped by 2.51% to $389000.0 in 2024, then fell by 22.37% to $302000.0 in 2025.
  • Its last three reported values are $302000.0 in Q2 2025, $347000.0 for Q1 2025, and $389000.0 during Q4 2024.